Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-02-Speech-3-288-000"

PredicateValue (sorted: default)
dcterms:Is Part Of
lpv:document identification number
lpv:translated text
"As a member of the delegation to the ACP-EU Joint Parliamentary Assembly, I am in favour of the results of EU research into the development of vaccines against tuberculosis being made available to developing countries, and of helping these countries to fund treatment for those suffering from the disease. Tuberculosis is one of the three most frequently occurring infectious diseases, along with HIV and malaria. One third of the world’s population is infected with the tubercle bacillus; every year, eight million people are diagnosed with the disease and it kills between 2.6 and 2.9 million. Over 95% of cases occur in developing countries. Every second, the tubercle bacillus claims another victim. Around 10% of those infected will go on to develop the disease, which can be deadly if left untreated. Most cases are diagnosed in India, China, Indonesia, South Africa, Nigeria, Bangladesh and Ethiopia. In Asia and Africa, incidence stands at 100-120 per 100 000 of population. Access to effective treatment is limited in many countries. Tuberculosis is a serious economic problem. The global fall in workforce productivity caused by the disease amounts to USD 13 billion every year. Eliminating tuberculosis is one of the Millennium Development Goals, which the EU wants to achieve by 2015. We already only have four years left. Tuberculosis is currently a fully treatable disease. We need comprehensive programmes aimed both at preventing and treating tuberculosis. An information campaign on tuberculosis and ways of avoiding and treating it should be launched as soon as possible, and a vaccination programme started."@en1

Named graphs describing this resource:


The resource appears as object in 2 triples

Context graph